Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive impairment in bipolar disorder treated with aripiprazole
2009-017581-22Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of aripiprazole in bipolar disorder (BD), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change in verbal memory function. Started Dec 2010; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2009-017581-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017581-22.